

Learn about common and serious Pristiq XR side effects from FDA labeling, how to manage them, and when to call your doctor right away.
Every medication comes with potential side effects, and Pristiq XR (Desvenlafaxine) is no exception. The good news is that most side effects are mild, manageable, and often improve within the first few weeks of treatment.
This guide covers the common and serious side effects of Pristiq XR based on FDA labeling, who may be more at risk, and when you should contact your doctor.
Pristiq XR is an extended-release serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat Major Depressive Disorder (MDD) in adults. It contains the active ingredient Desvenlafaxine, which is the active metabolite of Venlafaxine (Effexor XR). For more details, see our full guide on what Pristiq XR is and how it's used.
The following side effects were reported in clinical trials. Most are dose-related, meaning they're more likely at higher doses. Many improve after the first 1-2 weeks:
These side effects are generally mild to moderate. If any of them are persistent or bothersome, talk to your doctor — but don't stop taking Pristiq XR without medical guidance.
While less common, Pristiq XR can cause serious side effects that need immediate medical attention:
Pristiq XR carries a boxed warning — the FDA's most serious warning — about increased risk of suicidal thinking and behavior in children, adolescents, and young adults (ages 18-24), especially during the first few months of treatment or when doses change. Pristiq XR is not approved for use in children.
Call your doctor or 988 (Suicide & Crisis Lifeline) immediately if you experience new or worsening depression, anxiety, agitation, panic attacks, or thoughts of self-harm.
This is a rare but potentially life-threatening condition that can occur when too much serotonin builds up in your body. Symptoms include:
Risk increases if you take Pristiq XR with other serotonergic medications. See our guide on Pristiq XR drug interactions for the full list.
Pristiq XR can raise blood pressure because it affects norepinephrine. Your doctor should monitor your blood pressure before and during treatment.
SNRIs may increase bleeding risk, especially if you also take NSAIDs, Aspirin, or blood thinners.
Elderly patients may be more susceptible to hyponatremia (low sodium) and falls due to dizziness. Doctors may use lower starting doses.
Pristiq XR is Pregnancy Category C. Use during the third trimester may cause complications in the newborn, including difficulty breathing and feeding. Discuss the risks and benefits with your OB/GYN.
Dose adjustments are recommended: max 50 mg/day for severe kidney impairment and max 100 mg/day for moderate liver impairment.
Here are some practical tips for handling the most common side effects:
Stopping Pristiq XR suddenly can cause discontinuation syndrome, with symptoms like dizziness, nausea, headache, irritability, "brain zaps" (electric shock sensations), and vivid dreams. Always taper gradually under your doctor's supervision.
Most Pristiq XR side effects are mild and temporary. Nausea, dizziness, and sweating are the most commonly reported, and they often improve as your body adjusts. Serious side effects are rare but real — know the warning signs and don't hesitate to call your doctor.
If you're considering Pristiq XR or have just started, you can learn more about how it works or find a doctor who can answer your questions. And when you're ready to fill your prescription, Medfinder can help you locate a pharmacy with Pristiq XR in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.